Maiken Keson-Brookes, See Remarks at Mural Oncology plc (MURA), sold 2,572 shares at $2.48 ($6K) on 2025-07-22, disclosed to the SEC on 2025-07-23.
Scheduled sale ($6k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MURA | SELL | 2024-12-26 | $8K | — | Filing → |
| MURA | SELL | 2024-07-18 | $7K | — | Filing → |
| RUBY | SELL | 2022-02-01 | $18K | — | Filing → |